Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

188.87 -0.18 (-0.10%)
Official Closing Price Updated: 6:30 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
From Johnson & Johnson
Via Business Wire
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
San Francisco, CA – October 22, 2025 – Nurix Therapeutics (NASDAQ: NRIX) has captured significant market attention, with its stock experiencing a notable surge following the announcement of the... 
Via MarketMinute
Intuitive Surgical Soars on Stellar Q3 2025 Earnings, Driven by Da Vinci 5 Adoption
Intuitive Surgical (NASDAQ: ISRG), the global leader in robotic-assisted surgery, announced a robust third quarter for 2025, sending its stock soaring as investors cheered impressive financial results... 
Via MarketMinute
Topics Artificial Intelligence Earnings Intellectual Property
Kenvue Stock Climbs Premarket, Day After Record Slide On UK Lawsuit: Retail Bulls Remain Unshaken
Via Stocktwits
Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Ominous Echoes: U.S. Job Growth Stalls to 2009 Levels, Signaling Deep Labor Market Fragility
WASHINGTON D.C. – October 21, 2025 – A concerning report from investment giant Vanguard has cast a long shadow over the U.S. labor market, revealing that job growth plummeted to a mere 0.1% for seven... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Johnson & Johnson Draws Long-Term Buyers as Markets Turn Cautious
Johnson & Johnson Draws Long-Term Buyers as Markets Turn Cautious 
Via The Motley Fool
Topics Economy
IMF Sounds Alarm: Global Growth Slows, Developing Economies Face Mounting Debt Crisis
The International Monetary Fund (IMF) has issued a stark warning regarding the global economic outlook, projecting a deceleration in growth coupled with an alarming rise in debt risks for developing... 
Via MarketMinute
Topics Bonds Economy World Trade
Johnson Y-Axis Adjustment(R) (\"Ring Dinger(R)\") Clarified as In-Scope Care Under Texas Law; Advanced Chiropractic Equipment LLC Addresses Confusion with Y-Strap Traction
Houston, Texas--(Newsfile Corp. - October 20, 2025) - Advanced Chiropractic Equipment LLC (ACE) and Your Houston Chiropractor, Gregory E. Johnson,... 
Via Newsfile
The Industrial Giant's Resurgence: Why 3M (NYSE: MMM) Is Poised to Outperform the S&P 500 Over the Next Decade
After a decade of significant underperformance, marked by legal battles and strategic drift, industrial conglomerate 3M Company (NYSE: MMM) is now making aggressive moves to reclaim its former glory.... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Q3 2025 Earnings Season: A High-Stakes Quarter for Market Direction
The stage is set, and the curtains are about to rise on the Q3 2025 earnings season, a period historically known to inject both volatility and direction into the financial markets. As investors brace... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Global Trade Tensions: A Rollercoaster Ride for the Stock Market in October 2025
October 2025 has proven to be a turbulent month for global financial markets, as the persistent shadow of trade tensions and tariffs, particularly between the United States and China, continues to... 
Via MarketMinute
Topics Economy Electric Vehicles Government
3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October
These three stocks have elevated yields and attractive dividend histories. 
Via The Motley Fool
2 Top Dividend Kings Every Income Investor Should Own
These companies pay durable and steadily rising dividends. 
Via The Motley Fool
Topics Bonds
Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Global Economic Headwinds Intensify as China's Q3 GDP Forecast Signals Year-Low Growth, Sending Ripples Through International Markets
The global economy is bracing for a significant deceleration in 2025, a trend intensified by persistent trade tensions and widespread policy uncertainties. At the heart of this growing fragility lies... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
Kenvue could start to recover in 2026. 
Via The Motley Fool
Johnson & Johnson's M&A Strategy Is the Real Story for Investors
Johnson & Johnson’s rumored Protagonist buyout demonstrates its proven M&A strategy: divesting low-growth units to fund high-margin, innovative assets. 
Via MarketBeat
Why Kenvue Stock Tumbled by 13% on Thursday
The company's baby powder product is under legal fire once again. 
Via The Motley Fool
Topics Lawsuit
Global Markets Brace for Impact as Investor Risk Aversion Escalates Amidst Geopolitical Tensions and Economic Headwinds
Global financial markets are currently navigating a treacherous landscape marked by a pronounced surge in investor risk aversion. As of October 16, 2025, a potent cocktail of persistent geopolitical... 
Via MarketMinute
Topics Bonds Economy World Trade
Global Markets Brace for Turbulence: Credit Concerns and Geopolitical Tensions Fuel Volatility
Global financial markets are currently gripped by a palpable sense of unease and heightened volatility as October 2025 unfolds. A complex interplay of escalating geopolitical tensions, persistent... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Kenvue's Dual Dilemma: Tylenol and Talc Fears Trigger Sector Jitters
New York, NY – October 16, 2025 – The Consumer Staples and Healthcare sectors of the S&P 500 are experiencing a notable day of underperformance, largely overshadowed by the precipitous stock plunge of... 
Via MarketMinute
Topics Death Government Lawsuit
Fed Signals Further Easing Amid Uneven Inflation and Softening Labor Market: SF FedViews Points to More Rate Cuts
The Federal Reserve Bank of San Francisco's latest "SF FedViews" publication, released on October 16, 2025, offers a nuanced picture of the U.S. economy, highlighting inconsistent progress on inflation... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
Johnson & Johnson Plunges Amidst Escalating Talc Litigation: Billions at Stake as Legal Battles Intensify
New York, NY – October 16, 2025 – Johnson & Johnson (NYSE: JNJ), once considered a stalwart of stability, is currently navigating turbulent waters, finding itself among the market's bottom performers... 
Via MarketMinute
Topics Bankruptcy Death Lawsuit
Kenvue (KVUE) Plunges Amidst Dual Headwinds: Tylenol Fears and Escalating Talc Litigation
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As... 
Via MarketMinute
Topics Government Lawsuit
Investors Retreat to Safety: US Fund Flows Signal Defensive Stance Amidst Market Uncertainty
As October 2025 progresses, a palpable shift in investor sentiment is evident across US financial markets, with recent fund flow data signaling a clear pivot towards defensive strategies. Faced with... 
Via MarketMinute
Topics Bonds Economy
Johnson & Johnson Reports Strong Phase 3 Results For Multiple Myeloma Therapy
Tecvayli combined with Darzalex Faspro improves overall survival in relapsed/refractory multiple myeloma, Johnson & Johnson reports. 
Via Benzinga
Johnson & Johnson: Earnings Beat, High Technical Momentum, UK Talc Suits Loom
Johnson & Johnson's stock shows strong technical momentum following a modest earnings beat, but faces potential volatility due to ongoing UK talc lawsuits and a strategic orthopedics spinoff. 
Via Talk Markets
Topics Earnings Lawsuit
Jamison Loads Up on Johnson & Johnson (JNJ) Stock With a 39K Share Purchase
Via The Motley Fool
Topics Regulatory Compliance
Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims
Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks for decades. 
Via Benzinga
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.